Skip to main content
CG Invites Co., Ltd. logo

CG Invites Co., Ltd. — Investor Relations & Filings

Ticker · 083790 ISIN · KR7083790006 KO Manufacturing
Filings indexed 454 across all filing types
Latest filing 2026-06-09 Legal Proceedings Report
Country KR South Korea
Listing KO 083790

About CG Invites Co., Ltd.

https://cginvites.com/en

CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.

Recent filings

Filing Released Lang Actions
소송등의판결ㆍ결정(일정금액이상의청구) (약정금)
Legal Proceedings Report Classification · 88% confidence The document details a specific court judgment for a lawsuit involving the company (case number, parties, decision, judgment date, amount, court, etc.). It is an update on legal proceedings, not a financial report, management change, or other disclosure. This fits the definition of a Legal Proceedings Report (Code: LTR).
2026-06-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a required insider/major shareholder securities ownership report (“임원ㆍ주요주주 특정증권등 소유상황보고서”) filed by an executive describing personal holdings and changes in share ownership. This is a personal insider transaction disclosure by a director, which matches the definition of Director’s Dealing (DIRS).
2026-06-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a mandatory disclosure to the regulatory authorities (Securities and Futures Commission and Korea Exchange) detailing the holdings and transactions in the company’s securities by an executive (임원) and major shareholder. It lists share counts, ownership percentages, transaction dates, and prices. This matches the definition of a “Director’s Dealing” (insider transactions by executives) report.
2026-06-09 Korean
불성실공시법인지정예고 (공시변경)
Regulatory Filings Classification · 82% confidence The document is a Korean stock exchange regulatory notice regarding preliminary designation of the company as a non-diligent discloser (“불성실공시법인 지정예고”). It does not present financial statements, management changes, or voting results, but is a compliance announcement under exchange rules. This falls under miscellaneous regulatory filings.
2026-05-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean insider ownership report (“임원ㆍ주요주주 특정증권등 소유상황보고서”) detailing an executive’s shareholdings and changes (acquisitions/dispositions) in the company’s stock. It constitutes a report of personal share transactions by a company director (insider trading disclosure). Therefore it matches the Director's Dealing category.
2026-05-18 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” covering the period January 1 to March 31, 2026 (first quarter) for a listed company. It includes detailed financial tables, business overview, capital changes, board changes, and substantive financial data typical of a quarterly interim report. Therefore, it is classified as an Interim / Quarterly Report (IR). Q1 2026
2026-05-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.